Health ❯ Healthcare ❯ Clinical Trials

Phase 2 Studies

Tovorafenib Efficacy CELIA Study Eli Lilly Research NK/T-Cell Lymphoma DAHLIAS Study Drug Efficacy ASCERTAIN-V Study Lymphopenia Treatment Zenagamtide VK2735 PTC518

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

Data suggesting that lowering tau can slow Alzheimer’s progression have prompted Biogen to plan a pivotal Phase 3 in 2027.

One Infusion Cuts LDL by Up to 62% in Early Gene‑Editing Trial

FDA Clears All-Oral Decitabine/Cedazuridine Plus Venetoclax for Older AML Patients

EMA Panel Backs Conditional EU Approval for Ojemda in Pediatric Low-Grade Glioma